Medical Product Development and Regulatory Policy

Project

Reliable drug supply, Valuing availability, Advanced Manufacturing Technologies, and Patient-Center...

Project

Project

ReVAMP Drug Supply Chain Consortium: Manufacturing quality issues, public health emergencies, natural disasters, bioterrorism, geopolitical issues, and other supply and demand shocks all pose threats to patients in need of uninterrupted access to life-saving essential drugs. Duke-Margolis developed the ReVAMP Drug Supply Chain Consortium to generate effective policy solutions that promote a reliable drug supply chain.

Read more here.

More information:

Emerging Initiatives - Duke-Margolis Cell and Gene Policy Initiative and Enabling the Digital Health Revolution

Project Page - Duke-Margolis ReVAMP Drug Supply Chain Consortium

U.S. Food and Drug Administration: Click here for more information on our work with the U.S. Food and Drug Administration

Drug Repurposing: More information on our drug repurposing work coming soon.

Issue Spotlight: Strengthening Drug Supply Chain Reliability and Leveraging Advanced Manufacturing Technologies: Manufacturing quality issues, public health emergencies, natural disasters, bioterrorism, geopolitical issues, and other supply and demand shocks all pose threats to patients in need of uninterrupted access to life-saving essential drugs. Duke-Margolis developed the ReVAMP Drug Supply Chain Consortium to generate effective policy solutions that promote a reliable drug supply chain.

Read more here.

More information:

Emerging Initiatives - Duke-Margolis Cell and Gene Policy Initiative and Enabling the Digital Health Revolution

Project Page - Duke-Margolis ReVAMP Drug Supply Chain Consortium

Projects Relating to Medical Product Development and Regulatory Policy